Pilot study shows that an SGLT-2 inhibitor doses of 5-mg and 10-mg were associated with significant reductions in blood glucose and total daily insulin dose…. Dapagliflozin is a member of the SGLT2 inhibitor class of diabetic medications indicated only for treatment of type 2 diabetes. Dapagliflozin helps reduce blood glucose …
Read More »Best Insulin Regimen for Type 1’s
For people with type 1 diabetes, long-acting insulin may be a better treatment choice than intermediate-acting insulin…. Different types of insulin are used to manage type 1 diabetes with insulin injections. Long-acting insulin takes about one hour to begin lowering blood sugar levels and lasts up to 26 hours, while intermediate-acting …
Read More »EASD: Non-albuminuric CKD in Type 1 Diabetes Patients Increasing
Researchers are unsure why the phenotype is increasing but suggest that more effective treatments may be contributing to the increase in non-albuminuric CKD…. Chronic kidney disease (CKD) is a common complication of diabetes associated with glomerular filtration rate (GFR) loss. Normally, before the GFR loss occurs, albuminuria will be detected. …
Read More »Update: Islet Cell Transplantation for the Treatment of Type 1 Diabetes
Promising trial showed safe restoration of near-normoglycemia in type 1 diabetes…. Islet transplantation is a well-established therapeutic treatment for a subset of patients with difficult to control type 1 diabetes mellitus. Before the Edmonton Protocol, only 9% of the 267 islet transplant recipients since 1999 were insulin independent for more …
Read More »Handbook of Diabetes, 4th Edition, Excerpt #9: Management of Type 1 Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Modern management of type 1 diabetes comprises a package of measures including multiple daily injections for a more physiological insulin replacement; assessment of glycaemic control using blood glucose self-monitoring as well as clinic tests such as glycated haemoglobin (HbA1c); insulin dosage …
Read More »Sensor Implant Measures Blood pH in Type 1 Diabetes
The device, only tested in mice, also can release insulin to prevent acidosis….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes
A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….
Read More »A Link between Cesarean Delivery and Type 1 Diabetes?
Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….
Read More »New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body…. On July 17th 2014, the Juvenile Diabetes Research Foundation (JDRF) announced that their partner, ViaCyte, Inc. filed an Investigational New Drug …
Read More »Hypoglycemia Awareness improves with Self-Monitoring in Type 1 Diabetes
The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.